You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
28 August 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) on Friday unveiled three additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus, designed to address imaging and workflow need...
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, used alone or in combination with ezetimibe, in man...
28 August 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and German biotechnology company BioNTech SE (NASDAQ:BNTX) announced on Thursday that the US Food and Drug Administration (FDA) has approved their 2026-2027 COVID-19 vaccine formula ...
28 August 2026 - Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company based in Sydney, Australia, announced on Thursday new data showing that its lead asset, paxalisib, achieved a 100% clinical benefit rate in six ev...
28 August 2026 - Clinical-stage biopharmaceutical company Duality Biotherapeutics Inc (DualityBio) (HKEX: 09606) announced on Friday that it has entered into a collaboration and licence agreement with biotechnology company Genentech, a member of the ...
27 August 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) announced on Thursday that it has applied to the European Medicines Agency for approval of subcutaneous induction dosing of SKYRIZI (risankizumab) for adults with moderately to severel...
27 August 2026 - Biopharmaceutical companies AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Amgen Inc (NASDAQ:AMGN) on Thursday reported positive results from the Phase III CROSSING trial showing that Tezspire (tezepelumab) delivered statisticall...